NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $50,772 | -20.1% | 19,603 | +25.9% | 0.00% | – |
| Q1 2023 | $63,550 | -18.7% | 15,576 | 0.0% | 0.00% | – |
| Q4 2022 | $78,192 | -61.6% | 15,576 | 0.0% | 0.00% | – |
| Q3 2022 | $203,734 | +9.5% | 15,576 | +7.4% | 0.00% | – |
| Q2 2022 | $186,000 | -2.1% | 14,498 | +16.3% | 0.00% | – |
| Q1 2022 | $190,000 | -14.0% | 12,466 | 0.0% | 0.00% | – |
| Q4 2021 | $221,000 | -14.3% | 12,466 | +1.7% | 0.00% | -100.0% |
| Q3 2021 | $258,000 | +6.6% | 12,259 | 0.0% | 0.00% | – |
| Q2 2021 | $242,000 | -23.9% | 12,259 | +12.2% | 0.00% | -100.0% |
| Q1 2021 | $318,000 | +0.3% | 10,925 | +4.5% | 0.00% | 0.0% |
| Q4 2020 | $317,000 | +105.8% | 10,458 | -16.5% | 0.00% | – |
| Q1 2020 | $154,000 | -28.4% | 12,524 | +7.6% | 0.00% | – |
| Q4 2019 | $215,000 | – | 11,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |